Colistin and Carbapenem-Resistant <i>Acinetobacter baumannii</i> Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling
Resistance to the last-line antibiotics against invasive Gram-negative bacterial infection is a rising concern in public health. Multidrug resistant (MDR) <i>Acinetobacter baumannii</i> Aci46 can resist colistin and carbapenems with a minimum inhibitory concentration of 512 µg/mL as dete...
Main Authors: | Nalumon Thadtapong, Soraya Chaturongakul, Sunhapas Soodvilai, Padungsri Dubbs |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/10/9/1054 |
Similar Items
-
Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Preliminary Study
by: Rujipas Sirijatuphat, et al.
Published: (2022-11-01) -
Comparative genomics and molecular epidemiology of colistin-resistant Acinetobacter baumannii
by: Jovana Kabic, et al.
Published: (2023-01-01) -
Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021-07-01) -
In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021-07-01) -
The effect of colistin resistance-associated mutations on the fitness of Acinetobacter baumannii
by: Xinli Mu, et al.
Published: (2016-11-01)